Thomas Lennart Eklund

Thomas Lennart Eklund

Directeur/Membre du Conseil chez SURGICAL SCIENCE SWEDEN AB

Fortune : 11 M $ au 30/04/2024

57 ans
Health Technology
Finance
Commercial Services

Profil

Thomas Lennart Eklund is currently the Chief Executive Officer & Director at Tedsalus AB.
He is also serving as the Chairman at Immedica Pharma AB, Sedana Medical AG, Mabtech AB, Itrim Sverige AB, Swevet Piab AB, Circassia AB, Mabtech Holding AB, Mabtech Group Holding AB, Surgical Science Sweden AB, Boule Diagnostics AB, Memira Holding AB, Rodebjer Form AB, Tedcap AB, Swedencare AB, Alfred Berg ABN AMRO Capital Investment AB, GHP International AB, Bariatric & Diabetes Center Ajman AB, Excillum AB, Bio-Works Sweden AB, Impilo.
No 4 Holding Ii AB, Bioworks AB, Immedica Pharma Holding AB, Swedencare AB (publ), ADDvise Group AB (starting in 2024), and Impilo AB (as an Industrial Partner since 2017).
In the past, Mr. Eklund served as the Chairman of Keybroker AB, Moberg Pharma AB (from 2016 to 2019), GHP Specialty Care AB (from 2014 to 2016), and Immedica Pharma AB (in 2020).
He was also the Chairman of BoMill AB, Itrim Holding AB, Bomill Holding AB, Swevet Holding AB, and Sedana Medical AB.
Additionally, he held the position of Director at Aerocrine AB (from 2011 to 2012), Biotage AB (from 2006 to 2007), Affibody Medical AB, Investor Growth Capital AB (from 2002 to 2014), Swedish Orphan International Holding AB (from 2004 to 2010), Carmel Pharma AB, SciBase Holding AB (from 2017 to 2019), Newron Sweden AB (as Deputy Director), Neoventa Medical AB, Calliditas Therapeutics AB (from 2019 to 2020), Tobii AB, Memira AB, Dipylon Medical AB, Peseq AB, PocketMobile Communications AB, Vårdapoteket i Norden AB (in 2012), Neoventa Holding AB, Scibase Intressenter AB, Observe Medical International AB, Bio-Works Technologies AB, and SciBase AB.
Mr. Eklund obtained an MBA from the Stockholm School of Economics.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2022 950 000 ( 0,60% ) 5 M $ 30/04/2024
31/12/2023 1 666 464 ( 1,68% ) 3 M $ 30/04/2024
30/09/2022 2 762 368 ( 7,11% ) 3 M $ 30/04/2024
31/01/2024 299 344 ( 0,21% ) 219 272 $ 30/04/2024
31/01/2024 61 402 ( 14,49% ) 57 621 $ 30/04/2024
31/12/2022 1 000 ( 0,00% ) 14 313 $ 30/04/2024

Postes actifs de Thomas Lennart Eklund

SociétésPosteDébut
SWEDENCARE AB Directeur/Membre du Conseil 01/01/2016
BOULE DIAGNOSTICS AB Directeur/Membre du Conseil 01/01/2014
SURGICAL SCIENCE SWEDEN AB Directeur/Membre du Conseil 01/01/2017
ADDVISE GROUP AB Directeur/Membre du Conseil 03/05/2024
Directeur Général -
Directeur/Membre du Conseil -
Président -
Private Equity Investor 01/01/2017
Impilo No 4 Holding Ii AB Directeur/Membre du Conseil -
░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Tous les postes actifs de Thomas Lennart Eklund

Anciens postes connus de Thomas Lennart Eklund

SociétésPosteFin
░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░ ░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Thomas Lennart Eklund

Formation de Thomas Lennart Eklund

Stockholm School of Economics Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas Lennart Eklund

Relations

100 +

Relations au 1er degré

57

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées12
BIOTAGE AB

Health Technology

ADDVISE GROUP AB

Distribution Services

SCIBASE HOLDING AB (PUBL)

Health Technology

CALLIDITAS THERAPEUTICS AB

Health Technology

SURGICAL SCIENCE SWEDEN AB

Health Technology

BOULE DIAGNOSTICS AB

Health Technology

TOBII AB

Electronic Technology

MOBERG PHARMA AB

Health Technology

BOMILL AB

Technology Services

SWEDENCARE AB

Health Technology

BIO-WORKS TECHNOLOGIES AB

Health Technology

SEDANA MEDICAL AB

Health Technology

Entreprise privées44

Electronic Technology

Health Technology

Finance

Finance

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Services

Commercial Services

Technology Services

Retail Trade

Rodebjer Form AB

Miscellaneous

Scibase Intressenter AB

Distribution Services

Sedana Medical AG

Tedcap AB

Commercial Services

Consumer Services

Health Technology

Scibase AB

Bomill Holding AB

Alfred Berg ABN AMRO Capital Investment AB

Swevet Piab AB

Commercial Services

Finance

Bariatric & Diabetes Center Ajman AB

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Impilo No 4 Holding Ii AB

Bioworks AB

Immedica Pharma Holding AB

Finance

Mabtech Group Holding AB

Process Industries

Technology Services

Health Services

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas Lennart Eklund
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT